Skip to main content

NCBiotech News

  • If your early-stage life science company needs some funding help, you still have a few days to apply for a chance to pitch your company story to investors and colleagues at the 2016 annual Southeast BIO Investor & Partnering Forum.
  • As part of the celebration of the opening of SoBran's Greensboro animal research facility, the company and NCBiotech are co-sponsoring the Innovation for Impact Prize contest for researchers at North Carolina academic institutions and emerging companies – those with fewer than 50 employees and annual revenue under $10 million.
  • Traumatic brain injury has gained national prominence as star athletes have publicly acknowledged their struggles, and now the medical community is sounding the alarm about the prevalence of TBI among soldiers, who face comparable risks as they engage in rigorous training, athletics and combat.
  • More than 125 participated in a day-long symposium at NCBiotech, exploring the bioterrorism challenges our defense and military agencies are charged with assessing and solving, and some of North Carolina's capabilities for helping to deal with the issues.
  • BioFluidica, a Chapel Hill company developing a product using liquid biopsies for cancer detection. has completed a $2 million Series A funding round.
  • CivaTech Oncology, a Research Triangle Park company developing cancer therapy devices with funding help from the North Carolina Biotechnology Center, is featured in an abstract that will get a “Best in Show” award at an upcoming scientific meeting.
  • North Carolina’s life science jobs continue to grow at more than triple the national average, pushing the total num
  • Seventy-one companies headquartered in 20 countries now have a presence in North Carolina, employing more than 17,000 people in the state, where they have made capital investments totaling well over $2.5 billion in the past five years alone.
  • Carver Nichols, a senior honor student at Brevard High School, was a finalist in the BioGENEius Challenge, an international science fair in which North Carolina's lone 2016 finalist competed against 14 others from the United States, Canada and Germany.
  • Wilmington physician Alan Brown, an impassioned inventor in his off hours, has transformed two of his ideas into award-winning product innovations – a self-illuminating speculum and a corneal marking system – designed to make eye surgeries more efficient and accurate, improving patient outcomes.
  • A group headlined by blazingly successful life science rainmaker Steve Butts, MBA, is hanging out a shingle in Morrisville, this time with $49 million in early funding support. They’re calling it Arrivo BioVentures.
  • The uniquely futuristic billion-dollar cell culture Seqirus vaccine factory in Holly Springs has hit another milestone, with U.S. Food and Drug Administration marketing approval for the FLUCELVAX QUADRIVALENT flu vaccine made there.
  • Panacea BioMatx, a personalized nutrition startup company in Morrisville, has signed a license agreement with an Australian health food provider that will also invest up to $1 million in Panacea, while existing North Carolina investors in Panacea have also agreed to match the investment on similar terms.
  • Two North Carolina agricultural biotechnology leaders share their thoughts on the continuing need for innovation in agriculture, and North Carolina's growing power in driving the sector.
  • Custom development and manufacturing organization Alcami Corporation is hosting a public open house at its Durham facility on Thursday, May 19, from 11:30 a.m. to 3:30 p.m.
  • A Morehead City company using innovative materials to help restore North Carolina oyster habitats is among 11 finalists vying for $50,000 funding packages in the spring 2016 round of NC IDEA grants.
  • A dozen agricultural biotechnology companies from North Carolina, seven other states and even a European startup from Portugal will share their breakthrough technologies for crop and animal health advancements at the day-long Ag Biotech Entrepreneurial Showcase 2016 May 18 at the North Carolina Biotechnology Center.
  • FUJIFILM Diosynth Biotechnologies held a ribbon-cutting ceremony today to celebrate the opening of a 62,000-square-foot facility in Morrisville to house its bioprocess R&D groups.
  • Research Triangle Park-based medical diagnostics company BioMedomics has received approval from the Kenya Ministry of Health to sell Sickle SCAN, the company’s portable and quick-reporting test system for sickle cell disease (SCD) and sickle cell trait (SCT).
  • Plans for a new kind of agricultural technology startup company started to take shape today with the announcement of an $11.5 million AgTech Accelerator corporation in Research Triangle Park.

Pages

Subscribe to News & Events